Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | TOP1 | P11387 | 1/20 | 0.40 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.40 |
| ▸ | CASP6 | P55212 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL132985 | 0.93 | NPSR1 (0.44) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL14339294 | 0.91 | NPSR1 (0.43) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL14339283 | 0.91 | NPSR1 (0.43) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL9422307 | 0.89 | POLB (0.47) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL29644308 | 0.89 | POLB (0.47) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL14339296 | 0.88 | POLB (0.44) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL14339295 | 0.87 | LMNA (0.46) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL31463150 | 0.87 | HPRT1 (0.50) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL11991182 | 0.86 | NPSR1 (0.41) | NPSR1KMT2AMEN1POLBALDH1A1 | |
| SCHEMBL14339276 | 0.86 | LMNA (0.45) | NPSR1KMT2AMEN1POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3005433-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2023-02-22 | — | — | EP | disclosed |
| US-11535640-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| EP-3658564-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2021-05-19 | — | — | EP | disclosed |
| US-10889604-B2 | Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices | MERCK PATENT GMBH | 2021-01-12 | — | — | US | disclosed |
| EP-3117470-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| EP-3526228-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-11-25 | — | — | EP | disclosed |
| EP-3515925-B1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
| EP-3526226-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-07-22 | — | — | EP | disclosed |
| US-20200207794-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| US-20130168663-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2013-07-04 | — | — | US | disclosed |
| US-20120056169-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120056169-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2012-03-08 | — | — | US | disclosed |
| WO-2012013271-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2012-02-02 | — | — | WO | disclosed |
| EP-2251396-A2 | Mixture of organic emission-capable semiconductors and matrix materials, use of same and electronic components containing same | Merck Patent GmbH (DE) | 2010-11-17 | — | — | EP | disclosed |
| WO-2010108579-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2010-09-30 | — | — | WO | disclosed |
| US-7776455-B2 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2010-08-17 | — | — | US | disclosed |
| US-7776455-B2 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2010-08-17 | — | — | US | disclosed |
| US-20070170419-A1 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2007-07-26 | — | — | US | disclosed |
| US-20070170419-A1 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2007-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889604-B2 | Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices | PARN, PUF60, PARG | NPSR1 3472/4885KMT2A 2679/4885MEN1 3549/4885 |
| US-20200207794-A1 | METAL COMPLEXES | IMMT, MCU, SOD1 | NPSR1 2277/4885KMT2A 4304/4885MEN1 2301/4885 |
| US-11535640-B2 | Metal complexes | IMMT, MCU, SOD1 | NPSR1 2277/4885KMT2A 4304/4885MEN1 2301/4885 |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | AP2M1, MCU, AP3M1 | NPSR1 2996/4885KMT2A 4280/4885MEN1 3285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.